If you’re buying Curaleaf, you’ll be in the right place at the right time before this catalyst sends the stock price soaring…

Over the last several months, I’ve shown you why Curaleaf Holdings Inc. (OTC: CURLF) is one of the best cannabis stocks to own:

I’ve been adamant that now is the time to get off of the sidelines and buy shares or add to your current positions. Because if an act like the SAFE Banking Act passes, it would send cannabis stock prices skyrocketing.

That’s when we could see cannabis stocks “jumping” from over-the-counter markets (OTCMKTs) to the Nasdaq or New York Stock Exchange (NYSE). That “jump” can get complicated, and I don’t want you to get bogged down with how that will work.

All you really need to know is that it’s an event that will make you more money.

Because just one of the positive results of Curaleaf jumping from the OTC to a major United States exchange is that on Robinhood alone, there are 13 million users who will finally be able to buy shares.

Those Robinhood traders will throw their money at the stock, trying to buy as many shares as they can, putting that money directly into the pockets of those who had the foresight to own CURLF stock now.

Folks like you.

In fact, Robinhood just made a subtle but substantial move involving Curaleaf – one that my friend Norton Singhavon, the CEO of the Canadian cannabis company GTEC Holdings LTD (OTC: GGTTF), said was a “beta test.”

For something much bigger…

The Buy Signal Is Flashing for Curaleaf

Right now, Curaleaf is just on the watchlist of cannabis stocks listed on Robinhood.

You can’t actually buy it through Robinhood’s platform yet, but the fact that Robinhood added it to its watchlist is a massive step in the right direction.

So I had to find out if Norton thought this was as underrated as I did.

Check out what he had to say in this episode of Underrated or Overrated? – below:

I’ll be back this week with another round of NICI Snippets, which are the highlights from around the industry showcasing all of the positive momentum that’s building behind cannabis stocks.

Footnote: If you wanted to see more on why I believe Curaleaf will be the first household name in cannabis and receive my other Insider Field Reports each month, but aren’t currently a Cannabis Inner Circle subscriber, you’re free to find out how you can join my Inner Circle here.

Until then,


Danny Brody
Partner, RADD Capital


Comments

One response to “Underrated or Overrated? Robinhood Adds Curaleaf to Its Cannabis Stock Watchlist”

Leave a Reply

Your email address will not be published. Required fields are marked *